Skip to main content
. 2019 Sep;21(5):746–755. doi: 10.1016/j.jmoldx.2019.04.003

Table 1.

Commercially Available CYP2C9 Testing Platforms

CYP2C9 allele Affymetrix PharmacoScan (RUO) iPLEX ADME (RUO) INFINITI (CE-marked) eSensor (FDA-cleared)§ Defense analyte-specific reagents) OpenArray (V, RUO) TrimGen (FDA-cleared)
1B x
1C x
1D x
2 x x x x x x
2C x
3 x x x x x x
3A x
3B x
4 x x x
5 x x x
6 x x x
7 x
8 x x
9 x x
10 x x
11 x x
11A x
11B x
12 x x
13 x x
14 x
15 x x
16 x x
17 x x
18 x x
19 x x
20 x x
21 x x
22 x
23 x x
24 x x
25 x x
26 x x
27 x
28 x
29 x x
30 x x
31 x x
32 x x
33 x
34 x x
36 x
37 x
38 x
39 x
40 x
42 x
43 x
44 x
45 x
46 x
47 x
48 x
49 x
50 x
51 x
52 x
53 x
54 x
55 x
56 x
57 x
58 x

Commercially available platforms as of April 2, 2019 and does not represent a comprehensive list. Inclusion herein does not represent an endorsement of any product or service by AMP.

CE, Conformité Européenne; FDA, Food and Drug Administration; RUO, research use only; V, variable.

Thermo Fisher Scientific, (Waltham, MA).

Agena Biocience (San Diego, CA).

AutoGenomics (Carlsbad, CA).

§

GenMark Diagnostics (Carlsbad, CA).

BioFire Defense, LLC (Murray, UT).

TrimGen Genetic Diagnostics (Sparks, MD).